Company Filing History:
Years Active: 2001
Title: Innovations by Charles Durward Griffin
Introduction
Charles Durward Griffin is an accomplished inventor based in Leander, TX (US). He has made significant contributions to the field of medical devices, particularly in the development of heart valve prostheses. With a total of 2 patents to his name, Griffin's work has the potential to improve surgical outcomes for patients with heart conditions.
Latest Patents
Griffin's latest patents include a heart valve prosthesis with a resiliently deformable retaining member. This innovative valve body assembly is designed to be mounted adjacent to an annulus within the heart. The first retainer engages one side of the annulus, while the second retainer features a resiliently-deformable member that engages the opposite side. This design allows the retaining member to be collapsed for insertion and then expanded to securely engage the annulus.
Another notable patent is the stapled heart prosthesis and method of installing the same. This prosthetic heart valve includes a rigid shoulder with staple receiving means. By utilizing this feature, the heart valve can be quickly secured to the patient's tissue, significantly reducing the time required for installation compared to conventional valves. This innovation minimizes the risks and complications associated with heart surgery.
Career Highlights
Griffin is currently employed at Sulzer Carbomedics Inc., where he continues to work on advancing medical technologies. His expertise in the field has positioned him as a valuable asset to the company and the medical community.
Collaborations
Griffin collaborates with talented professionals, including Louis A. Campbell and Tammi E. Klostermeyer. Their combined efforts contribute to the development of innovative solutions in the medical device industry.
Conclusion
Charles Durward Griffin's contributions to heart valve technology exemplify the impact of innovation in medicine. His patents reflect a commitment to improving patient care and surgical efficiency. Through his work at Sulzer Carbomedics Inc., Griffin continues to push the boundaries of medical device development.